These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 4559547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC, Ahuja MM.
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract] [Full Text] [Related]

  • 4. The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
    Lenz PH, Fleischman AI.
    Lipids; 1971 Nov; 6(11):783-6. PubMed ID: 5127473
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].
    Fromantin M, Gautier D, Bon R.
    Sem Hop Ther; 1977 Nov; 53(5-6):311-6. PubMed ID: 897691
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P, Motolese M, Cerqua R, Mancini M.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth and luteinizing hormone decreases during nafenoic acid therapy.
    Danowski TS, Fisher ER, Gonzalez AR, Khurana RC, Jung Y, Hancock RA, Vester JW.
    Pol Med Sci Hist Bull; 1971 Oct; 14(4):148-53. PubMed ID: 5131072
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Focus on fenofibrate.
    Brown WV.
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract] [Full Text] [Related]

  • 14. [Hypolipidemic agents and their indication].
    Teramoto T.
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia.
    Wülfert B, Majoie B, de Ceaurriz A.
    Arzneimittelforschung; 1976 Mar; 26(5):906-9. PubMed ID: 183789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical trial of gugulipid--a new hypolipidemic agent of plant origin in primary hyperlipidemia.
    Agarwal RC, Singh SP, Saran RK, Das SK, Sinha N, Asthana OP, Gupta PP, Nityanand S, Dhawan BN, Agarwal SS.
    Indian J Med Res; 1986 Dec; 84():626-34. PubMed ID: 3552974
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.